Medicines eligible for Northern Ireland MHRA Authorised Route

AI Summary

The Medicines and Healthcare products Regulatory Agency (MHRA) maintains a comprehensive list of medicinal products eligible for supply to Northern Ireland through the Northern Ireland MHRA Authorised Route (NIMAR). This regulatory mechanism allows for the dispatch of specific medicines from Great Britain to Northern Ireland based on their existing authorizations within Great Britain. The primary objective is to ensure patients in Northern Ireland have uninterrupted access to essential treatments. The regulatory framework for this list is governed by Regulation 167B of the Human Medicines Regulations 2012 (SI 2012/1916, as amended). Because this document functions as a general regulatory guide rather than a specific enforcement report, it does not cite a specific company name, inspection dates, or violations. Instead, it outlines the legal basis for maintaining a stable supply chain across regions. The required action for stakeholders is to verify that any medicines intended for this supply route are officially registered on the NIMAR list to maintain compliance with UK law. This system ensures that clinical availability is preserved through transparent documentation and adherence to the established legal statutes.